Open Prostatectomy in Benign Prostatic Hyperplasia: 10-Year Experience in ItalyMearini E. · Marzi M. · Mearini L. · Zucchi A. · Porena M.
Urology Department, University of Perugia, Italy
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
This study reports the experience of 47 Italian urology units together with the urology unit at the University of Perugia concerning open surgery in the management of benign prostatic hyperplasia (BPH). Until 20–25 years ago, open surgery was the most common approach. In the late 1970s the development of endoscopes and their methodology has led to a gradual reduction in open surgery operations, which decreased rapidly with the introduction of mini-invasive endoscopic techniques. Therefore, open surgery for BPH is declining, though still performed. Skill in traditional surgery is mandatory because, until an alternative is devised, indications for open surgery still exist and cannot be ignored. The survey shows the indications and contraindications, complications and results of a 10-year nationwide experience. Guidelines for open surgery in patients with BPH have been drawn up.
Isaacs JT, Coffey DS: Etiology and disease process of benign prostatic hyperplasia. Prostate 1989;2(suppl):33–50.
Isaacs JT: Etiology of benign prostatic hyperplasia. Eur Urol 1994;25(suppl 1):6–9.
Fuller E: Six successfull and successive cases of prostatectomy. J Cutan Genitourin Dis 1895;13:229.
- Ohlsen H, Ekmann P, Ringertz H: Assessment of prostatic size with computed tomography. Acta Radiol Diagn 1982;23:219.
Rifkin MD: Diagnostic Imaging of the Lower Genitourinary Tract. New York, Raven Press, 1985.
Resnick MI: Editorial comment. J Urol 1983;129:50.
- Melchior J, Valk WL, Foret JD, Mebust WK: Transurethral prostatectomy: computerized analysis of 2,223 consecutive cases. J Urol 1974;112:634–639.
- Chilton CP, Morgan RJ, England HR, Paris AM, Blandy JP: A critical evaluation of the results of transurethral resection of the prostate. Br J Urol 1978;50:542–546.
- Neal DE: Prostatectomy – An open or closed case. Br J Urol 1990;66:449–454.
Marshall FF: Operative urology. 1991.
Anson K, Nawrocki J, Buckley J, et al: A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. J Urol 1995;46:305–310.
Meyhoff HH, Nordling J: Long term results of transurethral and transvesical prostatectomy. Scand J Urol Nephrol 1987;20:27–33.
Janknegt RA: Surgical management for benign prostatic hyperplasia. Prostate 1989(suppl 2):79–93.
- Hargreave TB, Stephenson TP: Potency and prostatectomy. Br J Urol 1977;49:683–688.
- Altwein JE, Keuler FU: Benign prostatic hyperplasia and erectile dysfunction: A review. Urol Int 1992;48:53–57.
- Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, Writing Committee: Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243–247.
- Malenka DJ, Roos NP, Fisher ES, et al: Further study of the increased mortality following transurethral prostatectomy: A chart-based analysis. J Urol 1990;144:224–228.
- Fowler FJ, Wennberg JE, Timothy RP, et al: Symptoms status and quality of life following prostatectomy. JAMA 1988;259:3018–3022.
- Wennberg JE, Roos NP, Sola L, et al: Use of claims data system to evaluate health care outcomes. Mortality and reoperation following prostatectomy. JAMA 1987;257:933–937.
- Roos NP, Wenneberg JE, Malenka DJ, Fisher ES, et al: Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989;320:1120–1124.
- Koshiba K, Egawa S, Ohori M, Uchida T, Yokoyama E, Shoji K: Does transurethral resection of the prostate pose a risk to life? 22-year outcome. J Urol 1995;153:1506–1509.
- Mozes B, Cohen YC, Olmer L, Shabtai E: Factors affecting change in quality of life after prostatectomy for benign prostatic hypertrophy: the impact of surgical techniques. J Urol 1996;155:191–196.
- Fourcade RO, Lanson Y, Teillac P: Results of the surgical treatment of benign hypertrophy of the prostate. Prog Urol 1993;3:823–915.
Kelly et al. (not available).
- Perkash I, Kataria PN, Takkar KL, Batra RS, Khanna OP: Evaluation of suprapubic prostatectomy using an absorbable purse-string suture at vesical neck. J Urol 1971;105:831–835.
- Nanninga JB, O’Conor VJ: Suprapubic prostatectomy: A 28 year review, 1942–1970. Int Urol Nephrol 1972;4:377–382.
- Nicoll GA, Riffle GN, Andersen FO: Suprapubic prostatectomy. The removable purse string: A continuing comparative analysis. J Urol 1978;120:702–704.
- Steg A: Transurethral versus open prostatectomy: Do these procedures apply to the same patients and the same disease? Eur Urol 1991;20:173–174.
- Finkle AL, Prian DV: Sexual potency in elderly men before and after prostatectomy. JAMA 1966;196:139–143.
- Cytron S, Simon D, Segenreich E, Leib Z, Servadio C: Changes in the sexual behavior of couples after prostatectomy: A prospective study. Eur Urol 1987;13:35–38.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.